Department of Public Health & Environment, Colorado Prescription Drug Profile
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Second Regular Session | 74th General Assembly
Colorado General AssemblyPresented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Committee Study Committee at its August 1, 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 1, 2017, meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Committee at its August 1, 2017, meeting.